AbCellera buys OrthoMab platform to move into bispecifics
AbCellera buys OrthoMab platform from Dualogics to enable development of bispecific antibodies.
AbCellera buys OrthoMab platform from Dualogics to enable development of bispecific antibodies.
European Commission lines up deal to buy 405 million COVID-19 vaccines from CureVac, swelling stockpile to 1.5 billion doses.
Lifting of French restrictions on stool collection clears microbiome player MaaT Pharma to start new manufacturing campaign.